Relationship of the expression of CD44v6 and Paxillin to the prognosis of non-small cell lung carcinoma

Journal of Sichuan University (Medical Science)

Volumn 34, Issue 3, 2003, Pages

  Zuo, Wanli ^a   Li, Haigang ^b  

^a Department of Respiratory Disease   (China)

^b NONE

Author keywords

CD44v6 Paxillin; Lung carcinoma; Neophlams Immunohistochemistry

Indexed keywords

CD44V6 ANTIGEN; PAXILLIN;

ARTICLE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

EID: 0141924646     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Christopher J, Anil K. CD44 isoform expression in primary and metastasis pancreatic adenocarcinoma. Cancer Research, 1995; 55(9):1831
2. Rudy W, Hofmann M, Schwartz-Albiez R, et al. The two major CD44 proteins expression on a metastatic rat tumor cell line are derived from different splice variants; each one individually suffices to confer metastatic behavior. Cancer Research, 1993; 53(6):1262
3. Harn HJ, Ho L, Chang JY, et al. Differential expression of the human metastasis adhesion molecule CD44 in normal and carcinomatous stomach mucosa of Chinese subjects. Cancer, 1995, 75(5):1065
4. Labarriere N, Piau JP, Dtry C, et al. H blood group antigen carried by CD44 modulates tumorigenicty of rat colon carcinoma cell. Cell Research, 1994; 54 (23):6275
5. Nakamura K, Yano H, Uchida H, et al. Tyrosine phosphorylation of paxillin alpha is involved in temporospatial regulation of paxillin-containing focal adhesion formation and F-actin organization in motile cells. J Biol Chem, 2000; 275(35): 27155
6. Turner CE. Paxillin interaction. J Cell Sci, 2000; 113(Pt23): 234139